These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 36912083

  • 21. Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain.
    Yamamoto Y, Takahata K, Kubota M, Takeuchi H, Moriguchi S, Sasaki T, Seki C, Endo H, Matsuoka K, Tagai K, Kimura Y, Kurose S, Mimura M, Kawamura K, Zhang MR, Higuchi M.
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3928-3936. PubMed ID: 37581725
    [Abstract] [Full Text] [Related]

  • 22. 11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
    Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.
    Mov Disord; 2018 Jan; 33(1):117-127. PubMed ID: 29082547
    [Abstract] [Full Text] [Related]

  • 23. Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.
    Gryglewski G, Rischka L, Philippe C, Hahn A, James GM, Klebermass E, Hienert M, Silberbauer L, Vanicek T, Kautzky A, Berroterán-Infante N, Nics L, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R.
    Neuroimage; 2017 Apr 01; 149():23-32. PubMed ID: 28119137
    [Abstract] [Full Text] [Related]

  • 24. Electroconvulsive therapy decreases striatal dopamine transporter binding in patients with depression: A positron emission tomography study with [18F]FE-PE2I.
    Masuoka T, Tateno A, Sakayori T, Tiger M, Kim W, Moriya H, Ueda S, Arakawa R, Okubo Y.
    Psychiatry Res Neuroimaging; 2020 Jul 30; 301():111086. PubMed ID: 32464340
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A.
    Neuropsychopharmacology; 2015 Jan 30; 40(2):472-9. PubMed ID: 25248987
    [Abstract] [Full Text] [Related]

  • 27. Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia.
    Momosaki S, Ito M, Yamato H, Iimori H, Sumiyoshi H, Morimoto K, Imamoto N, Watabe T, Shimosegawa E, Hatazawa J, Abe K.
    J Cereb Blood Flow Metab; 2017 Feb 30; 37(2):605-613. PubMed ID: 26911894
    [Abstract] [Full Text] [Related]

  • 28. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
    Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyás B, Halldin C.
    Synapse; 2009 Oct 30; 63(10):871-80. PubMed ID: 19562698
    [Abstract] [Full Text] [Related]

  • 29. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain.
    Yamamoto Y, Takahata K, Kubota M, Takano H, Takeuchi H, Kimura Y, Sano Y, Kurose S, Ito H, Mimura M, Higuchi M.
    Neuroimage; 2021 Feb 01; 226():117543. PubMed ID: 33186713
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain.
    Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H.
    Eur J Nucl Med Mol Imaging; 2020 Jul 01; 47(8):1927-1937. PubMed ID: 31788709
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In Vitro Ligand Binding Kinetics Explains the Pharmacokinetics of [18F]FE-PE2I in Dopamine Transporter PET Imaging.
    Kukk S, Loog O, Hiltunen JV, Järv J.
    ACS Med Chem Lett; 2018 Dec 13; 9(12):1292-1296. PubMed ID: 30613342
    [Abstract] [Full Text] [Related]

  • 35. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C.
    J Nucl Med; 2014 Jul 13; 55(7):1164-70. PubMed ID: 24790219
    [Abstract] [Full Text] [Related]

  • 36. Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression.
    Moriya H, Tiger M, Tateno A, Sakayori T, Masuoka T, Kim W, Arakawa R, Okubo Y.
    Psychiatry Clin Neurosci; 2020 Aug 13; 74(8):424-430. PubMed ID: 32363761
    [Abstract] [Full Text] [Related]

  • 37. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.
    Biol Psychiatry; 2005 Feb 01; 57(3):229-38. PubMed ID: 15691523
    [Abstract] [Full Text] [Related]

  • 38. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
    Smith GS, Ma Y, Dhawan V, Chaly T, Eidelberg D.
    Synapse; 2009 Jan 01; 63(1):1-6. PubMed ID: 18925655
    [Abstract] [Full Text] [Related]

  • 39. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect.
    Fazio P, Schain M, Mrzljak L, Amini N, Nag S, Al-Tawil N, Fitzer-Attas CJ, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A.
    Neuroimage; 2017 May 15; 152():330-339. PubMed ID: 28254508
    [Abstract] [Full Text] [Related]

  • 40. Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.
    Smith CT, San Juan MD, Dang LC, Katz DT, Perkins SF, Burgess LL, Cowan RL, Manning HC, Nickels ML, Claassen DO, Samanez-Larkin GR, Zald DH.
    Transl Psychiatry; 2018 Dec 07; 8(1):269. PubMed ID: 30531858
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.